Regulation of Cell Death and Inflammation by ISG15 during SARS-CoV2 Infection
Regulation of Cell Death and Inflammation by ISG15 during SARS-CoV2 Infection
批准号:
10287787
负责人:
Deborah J Lenschow
金额:
$19.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-06-08 至 2023-05-31
关键词:
2019-nCoVAdult Respiratory Distress SyndromeAffectAgeAnimal ModelApoptosisAvian InfluenzaCOVID-19COVID-19 patientCRISPR screenCaspaseCell DeathCellsCessation of lifeClinical ResearchCohort AnalysisComplexCoronavirusDataDevelopmentDiseaseElderlyEpithelial CellsEvaluationFunctional disorderFutureGoalsHMGB1 ProteinHistologicHistopathologyHumanISG15 geneImmune responseIn VitroInfectionInflammationInflammatoryInflammatory ResponseInflammatory Response PathwayInterferonsKnockout MiceLungMachine LearningMapsMolecularMorbidity - disease rateMusPathogenesisPathologyPathway interactionsPatientsPatternPlayPopulationProductionProteinsPulmonary InflammationRIPK3 geneRegulationRespiratory FailureRoleSARS-CoV-2 infectionSevere Acute Respiratory SyndromeSourceStructure of respiratory epitheliumSymptomsTestingTracheal EpitheliumTropismUbiquitin Like ProteinsViralViral Load resultViral ProteinsViral Respiratory Tract InfectionVirusVirus DiseasesVirus ReplicationWorkagedbasebiomarker identificationcell typechemokinecytokinecytokine release syndromediagnostic biomarkergenome-widehigh risk populationhuman coronavirusin vivoinsightmortalitynovelolder patientpandemic diseasesevere COVID-19systemic inflammatory responsetherapeutic developmenttherapeutically effective
中文摘要
SARS-CoV 2是一种高度传染性的新型人类冠状病毒,可导致冠状病毒疾病
2019年(COVID-19)。目前,美国已有超过740万人确认感染了
SARS-CoV 2和超过215,000人死亡。严重的COVID-19的特征是肺部和
全身性炎症和多器官功能障碍,严重影响老年人
患者SARS-CoV 2引发这种严重发病机制的机制尚不清楚,
明白最近的临床研究表明,细胞死亡,特别是诱导
坏死性凋亡可能是严重COVID-19疾病的预测因子。宿主通过这种机制
是否限制了坏死性凋亡尚不清楚。在初步的数据中,我们已经表明干扰素诱导的
ISG 15蛋白是坏死性凋亡及其下游炎症反应的负调节因子,
病毒感染时的反应。在这项提议中,我们将检验SARS-CoV 2
诱导坏死性凋亡,ISG 15在呼吸系统中作为坏死性凋亡的负调节剂发挥作用,
上皮细胞我们将使用体外原代气管上皮细胞培养物(hTEC)和体内培养物。
小鼠适应SARS-CoV 2动物模型提出了几个问题,包括:1)SARS-
CoV 2诱导呼吸道上皮细胞坏死性凋亡; 2)ISG 15是否调节坏死性细胞凋亡
呼吸道上皮细胞中的死亡以及促炎细胞因子/趋化因子产生
在SARS-CoV 2感染期间?3)坏死性凋亡和ISG 15对其的调节是否有助于
SARS-CoV 2发病机制?总的来说,我们的研究将提供重要的见解,
SARS-CoV 2感染的发病机制,并提供潜在的洞察机制,
严重的疾病,这可能会直接努力发展诊断标志物和未来
对策
英文摘要
SARS-CoV2 is a highly contagious, novel human coronavirus that causes coronavirus disease
2019 (COVID-19). Currently over 7.4 million people in the US have confirmed infection with
SARS-CoV2 and over 215,000 have died. Severe COVID-19 is characterized by pulmonary and
systemic inflammation and multi-organ dysfunction, which disproportionally affects elderly
patients. The mechanism by which SARS-CoV2 triggers such severe pathogenesis is poorly
understood. Recent clinical studies have suggested that cell death, especially the induction of
necroptosis, may be predictor of severe COVID-19 disease. The mechanism by which the host
restricts necroptosis is unclear. In the preliminary data we have shown that the interferon induced
protein, ISG15, acts as a negative regulator of necroptosis and its downstream inflammatory
responses during viral infection. In this proposal we will test the hypothesis that SARS-CoV2
induces necroptosis and that ISG15 functions as a negative regulator of necroptosis in respiratory
epithelial cells. We will use in vitro primary tracheal epithelial cultures (hTECs) and an in vivo
mouse adapted SARS-CoV2 animal model to ask several questions including: 1) Does SARS-
CoV2 induce necroptosis in respiratory epithelial cells; 2) Does ISG15 modulate necroptotic cell
death as well as proinflammatory cytokine/chemokine production in respiratory epithelial cells
during SARS-CoV2 infection?; 3) Does necroptosis and its regulation by ISG15 contribute to
SARS-CoV2 pathogenesis? Overall, our studies will provide important insight into the
pathogenesis of SARS-CoV2 infection and provide potential insight into mechanisms underlying
severe disease, which may direct efforts toward the development of diagnostic markers and future
countermeasures.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanistic characterization of SARS-CoV2 associated kidney injury
-
批准号:10319713
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2021
-
负责人:Deborah J Lenschow
-
依托单位:
Mechanistic characterization of SARS-CoV2 associated kidney injury
-
批准号:10427448
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2021
-
负责人:Deborah J Lenschow
-
依托单位:
Mechanistic characterization of SARS-CoV2 associated kidney injury
-
批准号:10619568
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2021
-
负责人:Deborah J Lenschow
-
依托单位:
Regulation of Cell Death and Inflammation by ISG15 during SARS-CoV2 Infection
-
批准号:10424558
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2021
-
负责人:Deborah J Lenschow
-
依托单位:
Washington University Rheumatic DiseasesResearch Resource-based Center
-
批准号:10472003
-
项目类别:
-
资助金额:$74.49万
-
财政年份:2018
-
负责人:Deborah J Lenschow
-
依托单位:
Washington University Rheumatic DiseasesResearch Resource-based Center
-
批准号:9764270
-
项目类别:
-
资助金额:$77.29万
-
财政年份:2018
-
负责人:Deborah J Lenschow
-
依托单位:
Washington University Rheumatic DiseasesResearch Resource-based Center
-
批准号:10019327
-
项目类别:
-
资助金额:$76.5万
-
财政年份:2018
-
负责人:Deborah J Lenschow
-
依托单位:
Washington University Rheumatic DiseasesResearch Resource-based Center
-
批准号:10251236
-
项目类别:
-
资助金额:$75.43万
-
财政年份:2018
-
负责人:Deborah J Lenschow
-
依托单位:
Washington University Rheumatic Diseases Research Resource-based Center
-
批准号:10704273
-
项目类别:
-
资助金额:$77.75万
-
财政年份:2018
-
负责人:Deborah J Lenschow
-
依托单位:
REGULATION OF INFLUENZA VIRUS INFECTION BY ISG15
-
批准号:8109260
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2009
-
负责人:Deborah J Lenschow
-
依托单位:
REGULATION OF HOST RESPONSES TO RESPIRATORY VIRAL INFECTION BY ISG15
-
批准号:9926208
-
项目类别:
-
资助金额:$39.36万
-
财政年份:2009
-
负责人:Deborah J Lenschow
-
依托单位:
REGULATION OF INFLUENZA VIRUS INFECTION BY ISG15
-
批准号:7564541
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2009
-
负责人:Deborah J Lenschow
-
依托单位:
REGULATION OF INFLUENZA VIRUS INFECTION BY ISG15
-
批准号:8305774
-
项目类别:
-
资助金额:$33.52万
-
财政年份:2009
-
负责人:Deborah J Lenschow
-
依托单位:
REGULATION OF INFLUENZA VIRUS INFECTION BY ISG15
-
批准号:7904131
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2009
-
负责人:Deborah J Lenschow
-
依托单位:
Role of ISG15 in the Pathogenesis of SLE
-
批准号:7680339
-
项目类别:
-
资助金额:$9.18万
-
财政年份:2008
-
负责人:Deborah J Lenschow
-
依托单位:
ISG15 REGULATION OF ANTIVIRAL IMMUNE RESPONSES
-
批准号:7487917
-
项目类别:
-
资助金额:$22.37万
-
财政年份:2007
-
负责人:Deborah J Lenschow
-
依托单位:
Role of 1SG15 in the Pathogenesis of SLE
-
批准号:7508978
-
项目类别:
-
资助金额:$7.38万
-
财政年份:2007
-
负责人:Deborah J Lenschow
-
依托单位:
ISG15 REGULATION OF ANTIVIRAL IMMUNE RESPONSES
-
批准号:7391498
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2007
-
负责人:Deborah J Lenschow
-
依托单位:
Function of ISG15 during Viral Infection
-
批准号:7013109
-
项目类别:
-
资助金额:$8.88万
-
财政年份:2004
-
负责人:Deborah J Lenschow
-
依托单位:
Function of ISG15 during Viral Infection
-
批准号:6879241
-
项目类别:
-
资助金额:$8.67万
-
财政年份:2004
-
负责人:Deborah J Lenschow
-
依托单位:
海外基金